Financials Galderma Group AG

Equities

GALD

CH1335392721

Personal Products

Market Closed - Swiss Exchange 11:30:42 2024-05-31 am EDT 5-day change 1st Jan Change
73.27 CHF -0.30% Intraday chart for Galderma Group AG -0.27% -.--%

Valuation

Fiscal Period: December 2024 2025 2026
Capitalization 1 19,292 - -
Enterprise Value (EV) 1 21,599 21,099 20,396
P/E ratio 92.7 x 39.2 x 25.2 x
Yield 0.12% 0.34% 0.6%
Capitalization / Revenue 4.38 x 3.89 x 3.4 x
EV / Revenue 4.9 x 4.25 x 3.6 x
EV / EBITDA 21.1 x 18.2 x 14.3 x
EV / FCF 300 x 46.4 x 30.3 x
FCF Yield 0.33% 2.16% 3.3%
Price to Book 2.47 x 2.34 x 2.18 x
Nbr of stocks (in thousands) 237,898 - -
Reference price 2 81.09 81.09 81.09
Announcement Date - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2024 2025 2026
Net sales 1 4,406 4,964 5,668
EBITDA 1 1,023 1,159 1,426
EBIT 1 677.1 1,021 1,307
Operating Margin 15.37% 20.56% 23.06%
Earnings before Tax (EBT) 1 323 612.5 943
Net income 1 205.7 468 749
Net margin 4.67% 9.43% 13.21%
EPS 2 0.8746 2.071 3.212
Free Cash Flow 1 72 455 674
FCF margin 1.63% 9.17% 11.89%
FCF Conversion (EBITDA) 7.04% 39.26% 47.28%
FCF Conversion (Net income) 35% 97.21% 89.99%
Dividend per Share 2 0.0979 0.2757 0.4850
Announcement Date - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2024 2025 2026
Net Debt 1 2,307 1,807 1,105
Net Cash position 1 - - -
Leverage (Debt/EBITDA) 2.256 x 1.56 x 0.7748 x
Free Cash Flow 1 72 455 674
ROE (net income / shareholders' equity) 6.86% 8.55% 10.6%
ROA (Net income/ Total Assets) - - -
Assets 1 - - -
Book Value Per Share 2 32.80 34.60 37.20
Cash Flow per Share 2 32.60 18.70 4.240
Capex 1 330 166 188
Capex / Sales 7.49% 3.35% 3.32%
Announcement Date - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
81.09 USD
Average target price
85.62 USD
Spread / Average Target
+5.59%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GALD Stock
  4. Financials Galderma Group AG